The growing prospects of cell-based therapies to Drive advances in cell cryopreservation processes
Cell Cryopreservation Market |
The
cell cryopreservation market is estimated to be valued at US$ 8,659.4 Million in 2022 and is expected to exhibit a CAGR of 22.4% over the forecast period 2022-2030, as highlighted in a new
report published by Coherent Market Insights.
Market Overview:
Cell cryopreservation involves storing cells at very low temperatures, usually
in liquid nitrogen, to maintain the viability and biological activity of the
cells over a long period of time. The process finds widespread applications in
biomedical research, embryonic stem cell therapies, regenerative medicine, and
medical diagnosis.
Market Dynamics:
The increasing R&D investments by pharmaceutical and biotech companies in
cell-based therapies are expected to boost the demand for cell cryopreservation
over the forecast period. Rapid developments in stem cell therapies and
regenerative medicine are also fueling the market growth. For instance,
mesenchymal stem cells derived from bone marrow, adipose tissue, and umbilical
cord blood are being extensively researched for regenerating damaged tissues.
The emergence of novel biological therapeutics such as chimeric antigen
receptor T-cell (CAR-T) therapies used in cancer treatments will further
support the need for reliable cryopreservation of these therapeutic cells.
Market key trends:
One of the key trends in the cell cryopreservation market is the rising
adoption of contract cell and gene therapy manufacturing. There is an
increasing preference for outsourcing manufacturing activities to specialized
contract service providers owing to their advantages such as access to advanced
infrastructure and expertise. This helps companies focus on their core areas of
research. Contract service providers assisting with various cryopreservation
needs from banking to distribution is driving the growth of the market.
SWOT Analysis
Strength: Cryopreservation helps maintain the viability and integrity of cells
and tissues for long term storage and future use. This makes it an integral
part of therapies involving stem cells and tissues.
Weakness: Initial high costs associated with setting up cryopreservation facilities
can limit its adoption. Strict regulations also increase compliance burden.
Opportunity: Growing stem cell research and regenerative medicine provides
scope for innovations in cryopreservation techniques and solutions. Rising
incidence of cancer is also boosting the demand.
Threats: Lack of trained professionals and standard operating protocols in some
regions pose procedural challenges. Equipment malfunctions can damage priceless
samples.
Key Takeaways
The Global
Cell Cryopreservation Market Size is expected to witness high growth, exhibiting
CAGR of 22.4% over the forecast period,
due to increasing prevalence of chronic diseases. The market size was valued at
US$ 8,659.4 Million in 2022.
Regional analysis: North America dominated the market in 2022 and is expected to maintain its position during the forecast
period. This is attributed to presence of advanced healthcare facilities, high
healthcare spending, and growing focus on personalized medicine in the region.
However, Asia Pacific is anticipated to exhibit the fastest growth rate owing
to rising research funding, growing stem cell banking industry and increasing
patients' population.
Key players operating in the cell cryopreservation market are General Electric
Company, Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe)
Limited, Miltenyi Biotec GmbH, BioLife Solutions Inc., HiMedia Laboratories
Pvt. Ltd., PromoCell GmbH, Corning Incorporated, Cooper Companies, Inc., Planer
PLC, Bio-Rad Laboratories India Pvt. Ltd, Abcam plc., AMSBIO, Biogenuix, and
Evia Bio. These players are focusing on new product launches, collaborations
and expansions to increase their market share.
Read More - https://www.insightprobing.com/cell-cryopreservation-market-share-demand-analysis-size-and-forecast/
Comments
Post a Comment